Reports

225 Results (Page 1 of 9)

Australia Markets Research Reports

Pharmaceuticals

Australia Cardiovascular Drugs Market Analysis

Australia Cardiovascular Drug Market is at around $1.67 Bn in 2022 and is projected to reach $2.51 Bn in 2030, exhibiting a CAGR of 5.3% during the forecast period. The customized medicine, digital health integration, and changing environment of the Australian cardiovascular drug industry all point to great potential for long-term growth in the sector. The market is dominated by key players like Bristol-Myers Squibb Co, Pfizer, Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca Inc., Sanofi-Aventis Inc., Novartis Pharmaceuticals, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

OTC & Nutraceuticals

Australia Nutritional Supplements Market Analysis

By 2030, it is anticipated that the Australian nutritional and supplements market will reach a value of $9.81 Bn from $4.58 Bn in 2022, growing at a CAGR of 10% during 2022-30. The market is primarily dominated by local players such as Blackmores, BioMedicals, Nutralife, and Life-Space. The market for nutrition and supplements in Australia is primarily driven by reimbursement scenarios, increasing customer awareness, and increasing disposable incomes. The Australian nutrition and supplements market in Australia is segmented by Type, Product, application, and Distribution Channel.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Healthcare Services

Australia Women Health Diagnostic Market Analysis

This report presents a strategic analysis of the Australia Women's Health Diagnostic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Australian Women's Health Diagnostic Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Pharmaceuticals

Australia Sleep Disorders Market Analysis

This report presents a strategic analysis of the Australia Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Australia Sleep Disorders Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Pharmaceuticals

Australia Retail Pharmacy Market Analysis

Australia's Retail Pharmacy Market is projected to grow from $12.46 Bn in 2022 to $23.76 Bn by 2030, registering a CAGR of 8.4% during the forecast period of 2022-30. It is anticipated that the Prescription Drugs segment will continue to hold the largest share during the forecast period. Chemist Warehouse is one of the largest retail pharmacy chains in Australia, with over 400 stores across the country. It is known for offering a wide range of products at competitive prices.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Pharmaceuticals

Australia Radiotherapy Market Analysis

By 2030, it is anticipated that the Australia Radiotherapy Market will reach a value of $148 Mn from $83 Mn in 2022, growing at a CAGR of 7.5% during 2022-2030. The Radiotherapy Therapeutics Market in Australia is dominated by a few domestic players such as Vision RT, Australian Radiotherapy, and GenesisCare. The radiotherapy market in Australia is segmented into different types, technologies, procedures, applications, and end-users. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Australian radiotherapy is increasing due to the rise in cancer cases in the country.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Pharmaceuticals

Australia Primary Hyperoxaluria (PH) Therapeutics Market Analysis

Australia's Primary Hyperoxaluria (PH) therapeutics market was valued at $2.1 Bn in 2022 and is estimated to expand at a CAGR of 19% from 2022 to 2030 and will reach $8.8 Bn in 2030. One of the main reasons propelling the growth of this market is Increasing awareness about rare and genetic disorders and an increase in clinical trial activity. The market is segmented by diagnostic method, treatment, and type. Some key players in this market are Biocodex, Chinook Therapeutics, Bridgebio Pharma, BioMarin Pharmaceuticals, Amarna Therapeutics, and others.

PUBLISHED: Mar, 2023 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999 $2999

Healthcare Services

Australia Patient Engagement Solutions Market Analysis

Australia's patient engagement solutions market is projected to grow from $204.12 Mn in 2022 to $570.12 Mn by 2030, registering a CAGR of 13.7% during the forecast period of 2022-30. The main factors driving the growth would be advancements in digital health, increasing healthcare spending, the growing prevalence of chronic diseases, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and end-user. Some of the major players include HotDoc, HealthEngine, MedAdvisor, Allscripts, Cerner, and Mckesson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Healthcare Services

Australia Palliative Care Market Analysis

Australia's palliative care market is projected to grow from $156.96 Mn in 2022 to $324.42 Mn by 2030, registering a CAGR of 9.5% during the forecast period of 2022–30. The main factors driving the growth would be as increasing prevalence of chronic diseases, the growing aging population, advancements in technology, and government support. The market is segmented by service type and by the end user. Some of the major players include Hammond Care, Japara Healthcare, Aveo Group, Brightwater Care Group, and Home Instead.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

OTC & Nutraceuticals

Australia Over The Counter (OTC) Analgesics Market Analysis

This report presents a strategic analysis of the Australian over-the-counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Australian over-the-counter (OTC) Analgesics Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Digital Health

Australia Electronic Records Management Solutions Market Analysis

Australia's electronic records management solutions market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by solution and deployment. Australia's electronic records management solutions market is growing as there is a rising need for effective digital data management in businesses across various sectors, including healthcare, government, and financial services. The key market players are Objective Corporation (AUS), RecordPoint (AUS), ELO Digital Office Australia (AUS), DocuWare Australia (AUS), OpenText (AUS), and others.

PUBLISHED: May, 2023 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Medical Devices

Australia ENT Devices Market Analysis

Australia's ENT Devices Market is projected to grow from $280 Mn in 2022 to $490 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Australian ENT devices market include CoreMed ENT, Zonemedical, and Teleflex Medical Australia.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Digital Health

Australia Digital Health Market Analysis

Australia's digital health market was valued at $2.5 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 20.10% from 2022 to 2030 and will reach $10.96 Bn in 2030. One of the main reasons propelling the growth of this market is rising smartphone adoption, improved internet connectivity, and improved healthcare. The market is segmented by product, by end-user, and by component. Some key players in this market are Alcidion Corp., Doctors on Demand Pty Ltd, Ellume Limited, Genie Solutions Pty Ltd, and Harrison-Al Pty Ltd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Pharmaceuticals

Australia Diabetes Therapeutics Market Analysis

Australia's diabetes therapeutics market is expected to grow from $1.72 Bn in 2022 to $4.03 Bn in 2030 with a CAGR of 11.2% for the forecasted year 2022-30. Various government initiatives such as the National Diabetes Services Scheme, the Pharmaceutical Benefits Scheme, the Insulin Pump Program, and Medicare provide diabetes assistance to Australian citizens, a significant factor driving the market's growth. The Australian diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. MycRx, Cynapse Bio, and Novartis are the major players in the Australian diabetes therapeutics market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Medical Devices

Australia Coronary Stents Market Analysis

Australia's Coronary Stents Market is expected to witness growth from $136 Mn in 2022 to $220 Mn in 2030 with a CAGR of 6.25% for the forecasted year 2022-30. In Australia, the coronary stent market is expanding as a result of the growing use of stenting treatments among medical professionals, such as cardiologists and interventional radiologists. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Endoluminal Sciences, Austramedex, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Medical Devices

Australia Contraceptive Devices Market Analysis

Australia's Contraceptive Devices Market is expected to witness growth from $155 Mn in 2022 to $320 Mn in 2030 with a CAGR of 9.50% for the forecasted year 2022-30. Australian women are becoming more aware of the value of family planning and contraception. As a result, there is now a higher need for contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Ansell, Lifestyles Healthcare, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Healthcare Services

Australia Connected Healthcare Market Analysis

The Australia-connected healthcare market is projected to grow from $796.32 Mn in 2022 to $6444.96 Mn by 2030, registering a CAGR of 29.9% during the forecast period of 2022-30. The main factors driving the growth would be the rising geriatric population, geographic challenges, technological innovation, and government investment. The market is segmented by type, function, and application. Some of the major players include Telstra Health, HealthEngine, ResApp, MyHealth1st, Apple, IBM and Microsoft.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Healthcare Services

Australia Cancer Pain Management Market Analysis

Australia's Cancer Pain Management market is projected to grow from $78.24 Mn in 2022 to $132.43 Mn by 2030, registering a CAGR of 6.8% during the forecast period of 2022-2030. The main factors driving the growth would be as growing private healthcare sector, aging population, government initiatives, and increasing cancer incidence. The market is segmented by drug type and by disease. Some of the major players include Little Green Pharma (AUS), Phebra (AUS), Pfizer, Teva Pharmaceuticals, and Sanofi

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Pharmaceuticals

Australia Breast Cancer Therapeutics Market Analysis

Increased incidence of breast cancer and the emergence of novel technologies for breast cancer treatments have propelled the Australian breast cancer therapeutics market from $218 Mn in 2022 to $641 Mn in 2030 with a CAGR of 14.4% for the year 2022-2030. The breast cancer therapeutics market is segmented by therapy, by cancer type, and by distribution channel. Novartis, GlaxoSmithKline Plc, and Kyowa Kirin Co. Ltd are leading players in the Australian breast cancer therapeutics market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Medical Devices

Australia Biomaterials in Healthcare Market Analysis

Australia Biomaterials Healthcare Market is expected to witness growth from $1.87 Bn in 2022 to $5.61 Bn in 2030 with a CAGR of 14.70% for the forecasted year 2022-30. The demand for biomaterials in Australia is being driven by the rising prevalence of diseases like periodontal disease, tooth decay, oral cancer, halitosis, and dental caries, which is anticipated to spur development in the country's biomaterial healthcare market. The market is segmented by type and by application. Some key players in this market include Anatomics, PolyNovo, OPED Australia, BASF SE, Johnson and Johnson, Medtronic, and Evonik Industries.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Pharmaceuticals

Australia Antifungal Drugs Market Analysis

This report presents a strategic analysis of the Australian antifungal Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Australian Antifungal Drugs Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

OTC & Nutraceuticals

Australia Over The Counter (OTC) Pharmaceuticals Market Analysis

Australia's over-the-counter (OTC) pharmaceuticals market size was valued at $1650 Mn in 2022 and is estimated to expand at a CAGR of 7.04% from 2022 to 2030 and will reach $2843.5 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Rare Diseases

Australia Multiple Myeloma Therapeutics Market Analysis

Australia's multiple myeloma therapeutics market was valued at $100 Mn in 2022 and is estimated to expand at a CAGR of 6% from 2022 to 2030 and will reach $160 Mn in 2030. One of the main reasons propelling the growth of this Market is Increasing healthcare expenditure, Increasing geriatric population. The Market is segmented by type, drug, and distribution channel. Some key players in this Market are CSL, Telix Pharmaceuticals, Mesoblast, Kazia Therapeutics, Immutep, Patrys, Actinogen Medical, Noxopharm, Prima BioMed, Polynovo, and others.

PUBLISHED: Mar, 2023 | FORMAT: PPT | LAST UPDATED: Sep, 2023 | PRICE: $3999

Pharmaceuticals

Australia Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis

Australia's Paroxysmal Nocturnal Hemoglobinuria (PNH) therapeutics market is expected to grow from $44 Mn in 2022 to $108 Mn in 2030 with a CAGR of 11.70% for the year 2022-2030. The therapeutic choices available to patients have considerably improved as a result of recent developments in the development of targeted medicines for PNH in Australia, such as complement inhibitors. The market is segmented by therapy, diagnostic test, by distribution channel. Some key players in this market include Mayne Pharma, Mesoblast, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen, CSL Behring, and Bioverativ.

PUBLISHED: May, 2023 | FORMAT: PPT | LAST UPDATED: Sep, 2023 | PRICE: $3999

Medical Devices

Australia Diabetes Devices Market Analysis

Australian Diabetes Devices Market is expected to witness growth from $273 Mn in 2022 to $532 Mn in 2030 with a CAGR of 8.70% for the forecasted year 2022-30. In Australia, the market for diabetes devices is expanding as a result of the rise in the number of people with the condition and the demand for diabetes devices that can assist people in managing their condition. The market is segmented by type and by the end user. Some key players in this market include Fairmont Medical Products, Cook Medical Australia, Johnson & Johnson, Medtronic, Roche, Ascensia diabetes care, and Dexcom.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Sep, 2023 | PRICE: $3999

subscribe to our newsletter
up